These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 20644268

  • 1. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, Jabeen SA, Suvarna A, Jayalakshmi SS, Meena AK, Borgohain R, Kaul S.
    Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
    [Abstract] [Full Text] [Related]

  • 2. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 3. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS, Lee KY, Han SW, Kim SH, Lee JY, Ahn SH, Kim DJ, Kim DI, Nam CM, Heo JH.
    J Neurol Sci; 2009 Jun 15; 281(1-2):69-73. PubMed ID: 19304298
    [Abstract] [Full Text] [Related]

  • 4. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE, Zacharatos H, Hassanzadeh B, El-Gengaihy A, AlKawi A, Shhadeh A, Kirmani JF.
    J Stroke Cerebrovasc Dis; 2010 Mar 15; 19(2):116-20. PubMed ID: 20189087
    [Abstract] [Full Text] [Related]

  • 5. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.
    Isr Med Assoc J; 2004 Feb 15; 6(2):70-4. PubMed ID: 14986460
    [Abstract] [Full Text] [Related]

  • 6. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA, Ummer K, Pradeep Kumar VG, Noone ML.
    Int J Stroke; 2014 Jun 15; 9(4):426-8. PubMed ID: 23981667
    [Abstract] [Full Text] [Related]

  • 7. Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008.
    Salam KA, Ummer K, Kumar VG, Noone ML, Laila A, Ragini J.
    J Clin Neurosci; 2009 Oct 15; 16(10):1276-8. PubMed ID: 19570685
    [Abstract] [Full Text] [Related]

  • 8. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.
    Li YH, Li MH, Zhao ZG, Bai QK.
    Neurol India; 2009 Oct 15; 57(4):426-33. PubMed ID: 19770543
    [Abstract] [Full Text] [Related]

  • 9. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
    Takagi T, Kato T, Sakai H, Nishimura Y.
    J Stroke Cerebrovasc Dis; 2014 Jan 15; 23(1):69-74. PubMed ID: 23164483
    [Abstract] [Full Text] [Related]

  • 10. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group.
    Ann Emerg Med; 2005 Sep 15; 46(3):243-52. PubMed ID: 16126134
    [Abstract] [Full Text] [Related]

  • 11. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T.
    N Engl J Med; 1999 Jun 10; 340(23):1781-7. PubMed ID: 10362821
    [Abstract] [Full Text] [Related]

  • 12. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
    Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Lundstadsveen MT, Thomassen L.
    J Stroke Cerebrovasc Dis; 2008 Jun 10; 17(3):141-6. PubMed ID: 18436155
    [Abstract] [Full Text] [Related]

  • 13. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J, Gracia-Gil J, Sopelana-Garay D, Ayo-Martín O, Vadillo-Bermejo A, Touza B, Peñalver-Pardines C, Zorita MD, Segura T.
    Rev Neurol; 2008 Jun 10; 46(1):7-12. PubMed ID: 18214820
    [Abstract] [Full Text] [Related]

  • 14. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
    Sobolewski P, Sledzińska M, Szczuchniak W, Hatalska-Zerebiec R, Grzesik M, Sobota A.
    Przegl Lek; 2012 Jun 10; 69(6):237-41. PubMed ID: 23094435
    [Abstract] [Full Text] [Related]

  • 15. Does intravenous rtPA benefit patients in the absence of CT angiographically visible intracranial occlusion?
    Sylaja PN, Dzialowski I, Puetz V, Eliasziw M, Hill MD, Krol A, O'Reilly C, Demchuk AM.
    Neurol India; 2009 Jun 10; 57(6):739-43. PubMed ID: 20139502
    [Abstract] [Full Text] [Related]

  • 16. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P.
    J Neurol Sci; 2004 Oct 15; 225(1-2):3-9. PubMed ID: 15465079
    [Abstract] [Full Text] [Related]

  • 17. Acute stroke management in the elderly.
    Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.
    Cerebrovasc Dis; 2007 Oct 15; 23(4):304-8. PubMed ID: 17199089
    [Abstract] [Full Text] [Related]

  • 18. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.
    Cerebrovasc Dis; 2007 Oct 15; 24(1):56-65. PubMed ID: 17519545
    [Abstract] [Full Text] [Related]

  • 19. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M.
    Cerebrovasc Dis; 2008 Oct 15; 25(1-2):129-35. PubMed ID: 18073466
    [Abstract] [Full Text] [Related]

  • 20. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial.
    Feng W, Vasquez G, Suri MF, Lakshminarayan K, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2011 Oct 15; 20(3):241-6. PubMed ID: 20621509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.